LORIMEL ADELINE LOPEZ-CULANAG
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LAS VEGAS, NV NPI 1821870650
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NV Novo Nordisk AS All categories
General Payments — all program years on this page
$176.76
- Category: General Payments
- Program years: PY2024
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $176.76 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $176.76 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $76.68 | 3 |
| Lilly USA, LLC | $56.40 | 4 |
| Amgen Inc. | $22.89 | 1 |
| Phathom Pharmaceuticals, Inc. | $20.79 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $176.76 | 9 |
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100354240 | Novo Nordisk Inc | $31.63 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100431493 | Novo Nordisk Inc | $22.91 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100452696 | Novo Nordisk Inc | $22.14 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117313771 | Amgen Inc. | $22.89 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135796978 | Lilly USA, LLC | $13.80 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135796980 | Lilly USA, LLC | $14.13 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135799482 | Lilly USA, LLC | $14.22 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135804112 | Lilly USA, LLC | $14.25 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151184340 | Phathom Pharmaceuticals, Inc. | $20.79 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.